Braidwell »

Kiniksa Pharmaceuticals Intl P Ord Shs Cl A shares owned by Braidwell

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals Intl P Ord Shs Cl A shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals Intl P Ord Shs Cl A held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A by Braidwell

Quarter filed Position value Share count Share price at filing
2024-06-30 $38M 2.1M 18.67

More positions owned by Braidwell

Guardant Health Note11/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Novocure Note11/0 (Principal)
Nuvasive Note 0.375% 3/1 (Principal)
Neurocrine Biosciences (NBIX)
Cg Oncology (CGON)
Xenon Pharmaceuticals (XENE)
Apogee Therapeutics (APGE)
Neogenomics Note 0.250% 1/1 (Principal)
Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal)
Dexcom Note 0.375% 5/1 (Principal)
Guardant Health (GH)
Insulet Corp Note 0.375% 9/0 (Principal)
Legend Biotech Corp Sponsored Ads (LEGN)
Dexcom Note 0.250%11/1 (Principal)

View all positions for Braidwell

Top funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

BlackRock
Fairmount Funds Management
Hillhouse Capital Advisors
Baker Bros. Advisors
Rubric Capital Management
Braidwell
Morgan Stanley
State Street Corporation
Geode Capital Management
Nuveen Asset Management
Dimensional Fund Advisors
Parkman Healthcare Partners
Tang Capital Management
Millennium Management
Driehaus Capital Management

View all funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A